9-127810966-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004957.6(FPGS):c.1309G>A(p.Val437Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000111 in 1,583,342 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V437D) has been classified as Likely benign.
Frequency
Consequence
NM_004957.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FPGS | NM_004957.6 | c.1309G>A | p.Val437Ile | missense_variant | 14/15 | ENST00000373247.7 | NP_004948.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FPGS | ENST00000373247.7 | c.1309G>A | p.Val437Ile | missense_variant | 14/15 | 1 | NM_004957.6 | ENSP00000362344 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000813 AC: 18AN: 221392Hom.: 0 AF XY: 0.000101 AC XY: 12AN XY: 118980
GnomAD4 exome AF: 0.000108 AC: 154AN: 1431124Hom.: 0 Cov.: 27 AF XY: 0.000105 AC XY: 75AN XY: 710926
GnomAD4 genome AF: 0.000138 AC: 21AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74426
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.1309G>A (p.V437I) alteration is located in exon 14 (coding exon 14) of the FPGS gene. This alteration results from a G to A substitution at nucleotide position 1309, causing the valine (V) at amino acid position 437 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at